EPS

NAPCO Security Technologies heads to key investor conferences, armed with record profits, soaring recurring revenues, and a strong market position.

With its stock soaring, AGF Management renews its buyback plan to repurchase 10% of its public float, a strategic move to boost value and manage dilution.

Investors brace for South Bow's year-end results, seeking answers on pipeline repairs, new project cash flows, and its strategy in a shifting energy market.

Facing a stock slump and operational woes, Clorox leaders must deliver a convincing turnaround plan at the upcoming CAGNY investor conference.

The South Korean tobacco giant hits record revenue as its international strategy pays off, while it diversifies into nicotine pouches for future growth.

The semiconductor giant posted a huge Non-GAAP profit but a stunning IFRS loss for 2025. What's behind the numbers and why are investors cheering?

Life sciences giant QIAGEN defies economic headwinds with strong 2025 results, signaling aggressive growth in single-cell analysis and bioinformatics.

The frozen potato giant appoints an AB InBev veteran as Executive Chair and a new CFO, signaling a major push for global expansion and shareholder value.

Aramark has increased its quarterly dividend, a move reflecting strong financials. But what does it say about its strategy in a changing global market?

As Crown Crafts preps its Q3 earnings, investors watch to see if strategic shifts can overcome financial pressures in the competitive juvenile products market.

Precision medicine firm Atropos Health joins NY's elite digital health startups, signaling a market shift toward scalable, data-driven healthcare solutions.

McCain Foods launches its third 'Farm of the Future' in the UK, showcasing major strides in regenerative agriculture and setting ambitious 2030 climate goals.

With strong 2025 results as a tailwind, Agilent's upcoming Q1 earnings report will test its ambitious guidance and signal trends for the life sciences industry.

Investors sue Bitdeer, alleging the company misled them about its advanced crypto mining chip's progress, leading to significant stock price declines.

As Sagicor sets to unveil its 2025 year-end financials, investors eye key metrics and strategic shifts in a complex economic landscape.

Investors eye Rockwell Automation's upcoming conference for insights on its software growth, AI integration, and strategy for navigating economic headwinds.

With surging revenues and a new body contouring system, Apyx Medical heads to the BTIG conference to prove its growth story is here to stay.

NewcelX sharpens its focus on a Type 1 Diabetes cell therapy, but faces a competitive landscape and significant financial hurdles in its ambitious quest.

As NAPCO prepares its Q2 results, investors watch if its high-margin service revenue can offset market volatility and solidify its edge in school safety.

Generac's upcoming earnings report will reveal its navigation of a weak outage year while chasing a data center boom. What does it mean for investors?